Stock Groups

EU regulators impose interim measures against Illumina in Grail deal By Reuters


© Reuters. FILEPHOTO: This is a photograph showing a building at Illumina’s campus in San Diego. It was taken on September 1, 2021. REUTERS/Mike Blake

BRUSSELS (Reuters) – EU antitrust regulators on Monday announced interim measures against U.S. life sciences company Illumina (NASDAQ:) for for closing its $8 billion cash-and-stock takeover of cancer detection test maker Grail deal before gaining approval.

The European Commission stated that these measures were designed to maintain and restore effective competition, while it reviews the Illumina acquisition of Grail.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are provided by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.